USSTOCK.TODAY
After-Market
Log in Sign up

Myriad Genetics to sell prenatal health business to LabCorp for $210 million

The Motley Fool +1 · ·by G4L

MYGN
MYGN Myriad Genetics Inc
$5.74 -3.04%
View chart & analysis →
  1. 1Myriad Genetics will sell its prenatal health business to LabCorp in a $210 million cash deal including inventory.
  2. 2Myriad Genetics recorded total revenue of $202.7 million in the third quarter.
  3. 3The sale is expected to expand gross margins by more than 500bp and accelerate a sustainable profitability path.

So what's the key point?

Myriad Genetics has decided to sell its prenatal health business to LabCorp for $210 million. This sale will increase the company's profit margins and help it generate more profit.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Myriad Genetics beats revenue and loss per share estimates Earnings Whispers +1 · 4d agoMyriad Genetics to sell prenatal health testing business to Labcorp for $210 million Nasdaq +1 · Oct 21Amazon Winds Down Most of Its Core Nova Models in AI Strategy Overhaul Reuters +5 · Jul 29
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news